Old Web
English
Sign In
Acemap
>
Paper
>
PND47 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Relapsing Forms of Multiple Sclerosis
PND47 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Relapsing Forms of Multiple Sclerosis
2020
D. Di Maio
Liu Chu-heng
G Marcelli
J. Sánchez Alvarez
J Overell
Keywords:
Socioeconomic status
Ocrelizumab
Multiple sclerosis
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]